Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma
NCT06044506
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Autologous Natural Killer Cell Therapy
DEVICE:
Clinimacs Plus
Sponsor
Dr Cipto Mangunkusumo General Hospital